ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 126 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,774,000 | +34.4% | 129,992 | +1.0% | 0.00% | 0.0% |
| Q4 2018 | $1,320,000 | -67.0% | 128,744 | -46.4% | 0.00% | 0.0% |
| Q3 2018 | $3,998,000 | +118.4% | 240,086 | +107.2% | 0.00% | 0.0% |
| Q2 2018 | $1,831,000 | +20.7% | 115,869 | -3.0% | 0.00% | 0.0% |
| Q1 2018 | $1,517,000 | +9.5% | 119,410 | -1.3% | 0.00% | 0.0% |
| Q4 2017 | $1,385,000 | +19.4% | 120,931 | +27.7% | 0.00% | 0.0% |
| Q3 2017 | $1,160,000 | +19.6% | 94,698 | +11.8% | 0.00% | +100.0% |
| Q2 2017 | $970,000 | -42.9% | 84,705 | +3.8% | 0.00% | -50.0% |
| Q1 2017 | $1,698,000 | +6.3% | 81,614 | +6.3% | 0.00% | -33.3% |
| Q4 2016 | $1,598,000 | -35.5% | 76,809 | +1.5% | 0.00% | -25.0% |
| Q3 2016 | $2,479,000 | +32.9% | 75,638 | +1.3% | 0.00% | +33.3% |
| Q2 2016 | $1,865,000 | +118.9% | 74,671 | +114.6% | 0.00% | +50.0% |
| Q1 2016 | $852,000 | -77.3% | 34,795 | -69.4% | 0.00% | -71.4% |
| Q4 2015 | $3,750,000 | -21.7% | 113,545 | -22.3% | 0.01% | -30.0% |
| Q3 2015 | $4,790,000 | -47.4% | 146,205 | -15.0% | 0.01% | -41.2% |
| Q2 2015 | $9,107,000 | +145.9% | 171,922 | +34.0% | 0.02% | +142.9% |
| Q1 2015 | $3,704,000 | +1015.7% | 128,342 | +1024.0% | 0.01% | +600.0% |
| Q4 2014 | $332,000 | +129.0% | 11,418 | 0.0% | 0.00% | – |
| Q3 2014 | $145,000 | -36.7% | 11,418 | 0.0% | 0.00% | – |
| Q2 2014 | $229,000 | – | 11,418 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|